Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Transgenomic launches new mutation detection kits for fluorescent capillary electrophoresis
February 12th, 2007
Transgenomic, Inc. (TBIO) announced that it is launching its next generation Surveyor mutation detection kits for universal primer fluorescent capillary electrophoresis. The kits detect mismatch mutations in DNA that has been PCR amplified using two fluorescent primers and digested with Surveyor Nuclease. This then allows highly sensitive mutation detection on Applied Biosystems DNA sequencing instruments. It will be a key tool for scientists needing high-throughput analysis of genetic variation, even for those variations present at very low levels such as somatic mutations linked to cancer and its treatment. Introduced by Transgenomic in 2004,...
Source: Managed Care Weekly Digest (2007-02-12)
|
